Incoming! The Pfizer RSV Vaccine
Pfizer's new RSV vaccine may trigger Guillain-Barre syndrome
This is getting out of hand…
If you haven’t heard Pfizer is getting its latest vaccine ready - this time it’s for respiratory syncytial virus or RSV.
The new vaccine has been flagged by the Food and Drug Administration as posing a potential risk for Guillain-Barre syndrome, a rare neurological condition. According to FDA documents two people in their 60…
Keep reading with a 7-day free trial
Subscribe to Dr. Panda's Newsletter to keep reading this post and get 7 days of free access to the full post archives.